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OBJECTIVES:The first objective was to assess the two-year changes in quality of life
after gastric bypass in patients with severe obesity. Second, we analysed the effect
of weight reduction on the different HRQL dimensions in the framework of the
International Classification of Functioning, Disability and Health (ICF). METHODS:
We carried out a prospective intervention study with consecutive patients referred
to two bariatric surgical units in the Basque Country. We included generic (SF-36,
EuroQuol 5D) and specific questionnaires (Moorehead-Ardelt, Obesity-related
Problems scale). The SF-36 mental and physical dimensions and stigma theory,
allowed us to apply an approach based on the ICF. We measured effect size (ES),
standardized response mean (SRM) and ROC curves. RESULTS: Of 82 operated pa-
tients, 79 were tracked for 2 years. Average weight loss was 49 kg (28%) and BMI was
reduced from 50.6 to 31.8. The initial problems and the final improvements were
larger in the physical dimensions. The benefit of treatment was large for almost all
HRQL domains as measured by EQ-5D, SF-36, OP and Moorehead-Ardelt. Only the
improvements in some of the mental domains of the SF-36 were classified as small
or moderate. ROC curves were not sensitive to change in BMI. CONCLUSIONS: We
suggest that the negative impact of severe obesity on HRQL is mainly a cause of
disability as described in the ICF. Two-year improvements in HRQL are related to
recovery from disability after gastric bypass treatment. The primary focus on the
physical dimension is not contradictory with evidence of the impact of weight-
related stigmatization in obese individuals at the social level and its consequences
in mental health. In the ICF framework,
Surgery – Research On Methods
PSU27
FRACTURE RELATED TREATMENTS AFTER PRIMARY SURGICAL
INTERVENTIONS OF HIP FRACTURE EIGHT YEARS FOLLOW UP
Sebestyén A1, Gresz M2, Patczai B3, Mintál T3, Varga S3, Molics B3, Boncz I3
1South-Trasdanubian Regional Health Insurance Fund Administration, Pécs, Hungary, 2National
Health Insurance Fund Administration, Budapest, Hungary, 3University of Pécs, Pécs, Hungary
OBJECTIVES:The aim of our retrospective study was to analyze the further fracture
related treatment/complication after primary treatment of femur neck fracture
according to most frequently used types of operation. METHODS: The data derive
from the financial database of the Hungarian National Health Insurance Fund Ad-
ministration, based on the 10th revision of the International Classification of Dis-
eases (ICD) with ICD code S7200. The following patients were included into the
study: having social insurance identification number, being discharged from hos-
pitals in 2000 after primary treatment of femur neck fracture, over the age 60. The
patients with polytrauma or high energy trauma patient were excluded from the
study. During the 8 year follow up period the further fracture related treatment and
complications were analyzed according to the most frequently used types of
operation. RESULTS: Altogether 3783 patients were included into the study. The
distribution of primary surgical intervention was: arthroplasty 12.5%, screw fixa-
tion 73.6%, dynamic hip screw (DHS) 5.1%, femoral neck nailing 5.0%, Ender nailing
1.8%, Gamma nailing 1%, others 1 %. The fracture related treatment rate was 14,5%.
The main types of further fracture related treatments are listed: 5.7% hip replace-
ment, metalwork removal 3.6%, replacement of implants 2.48%, aseptic and septic
look: 1.7%, 0.7% resection arthroplasties. The further fracture related treatment
rate according to the most frequently used types of operation: arthroplasty 4.8 %,
screw fixation: 16.1 %, DHS: 7.8%, femoral neck nailing: 21.5%, Ender nailing: 19.4 %,
Gamma nailing: 2.4%. CONCLUSIONS: The methods, providing quickly full weight
bearing (Gamma nailing, DHS, hip arthroplasty) had lower complication rate, while
the methods (screw fixation, Ender nailing, femoral neck nailing) providing partial
weight bearing had higher complication rate. The backgrounds of fracture related
treatments should be investigated in the future.
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OBJECTIVES: Brain metastases occur in a majority of patients with malignant
disease and result in decreased quantity and quality of life. Treatment alterna-
tives range from whole brain radiation therapy (WBRT), neurosurgery, and the
newest modality, stereotactic radiosurgery (SRS). This article reviews economic
evaluations of SRS in the metastatic setting and compares to other treatment
options. METHODS: Studies were included if they were published in peer reviewed
journals, primarily in patients with malignant brain metastasis, and at least in-
cluded a cost analysis between interventions RESULTS: Uncertainty surrounding
the cost-effectiveness of SRS exits due to lack of efficacy information between
treatment alternatives, methodological limitations, and design differences be-
tween the available studies. However, when cost –effectiveness ratios are avail-
able, SRS appears to be a reasonable option in resource limited settings, with in-
cremental cost-effectiveness ratios (ICERS) just below the $50,000 range.
CONCLUSIONS: Better designed economic analysis in the setting of randomized
clinical trials or observational studies need to be conducted to fully understand the
economic value of SRS.
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OBJECTIVES: Thailand has been one of the leading developing countries to imple-
ment a national program to prevent mother-to-child transmission (PMTCT) of HIV.
The objective of this study was to determine the impact of pharmacist intervention
to monitor HIV-infected pregnant women. Pharmacist provided medication and
guideline information including phamacotherapeutic suggestion. METHODS: In
this research, retrospective study was employed with descriptive statistics using
average percentage frequency, making use of out-patients records of treatments in
HIV-infected pregnant women who informed about the benefits of taking antiret-
roviral (ARV) drugs for PMTCT, side effects of ARV drugs, importance of adherence
to drugs and the fact that HIV transmission to their infants can possibly occur
despite ARV use by pharmacist. RESULTS: The HIV-infected pregnant women
group of 24 cases, 4 were withdrawn due to unable to follow up, 20 cases have been
followed-up and shown the effectiveness of medicine. There were 8 new patients
(33.33%) firstly received ARV. The mean CD4 cell counts at baseline of all patients
were 227-69.28 cells/mm3. Most regimens for treatment was highly active anti-
retroviral therapy containing zidovudine (AZT)lamivudine (3TC)lopinavir/
ritonavir (LPV/rtv) 41.67% where treated with AZT3TCnevirapine were secondly
used (33.33%). It was found that 34.4% of patients had adverse drug reactions. The
ADR incidence of ARV was 4.0 patients and 6.2 events per 1000 person-day. Gas-
trointestinal system such as nausea and vomiting were found at 12.50% and 8.33%
were diarrhea were the most organ system affected. During the study period, 3
patients had to change ARV regimens because of ADRs. 16.67% were non-compli-
ance but less than 7 days at early period. The rate of MTCT of HIV was 8.33% after
monitoring for one year. CONCLUSIONS: The results indicated that a medication
monitoring and evaluating process by pharmacist associated with improved ratio-
nal used of drug in HIV-infected pregnant women. This project provides a founda-
tion for future quality improvement.
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OBJECTIVES: The aim of this study was to assess efficacy and safety of tenofovir
(TDF) as compared to other nucleot(s)ide analogues (NAs), i.e. lamivudine (LAM),
adefovir (ADV) and entecavir (ETV) in the treatment of chronic hepatitis B virus
(HBV) infection.METHODS:Assessment was based on randomized controlled trials
(RCTs) identified by means of systematic review, carried out according to the Co-
chrane Collaboration guidelines. Studies met the inclusion criteria if they directly
compared at least two of following interventions: TDF, LAM, ADV, ETV or placebo.
The electronic medical databases (EMBASE, MEDLINE, CENTRAL) were searched.
Two reviewers independently selected trials, assessed their quality and extracted
data. Mixed treatment comparison (MTC) was performed with WinBugs software. If
feasible, subgroup analyses were performed according to hepatitis B antigen e
(HBeAg) and or LAM resistance status. RESULTS: We identified 30 relevant studies
(6674 patients) with 12-144 weeks of follow-up . MTC showed that TDF increased
the chance of HBV DNA clearance at the end of treatment period as compared to
ADV (OR  13,16 [3,21; 54,20]), LAM (OR  61,09 [11,10; 503,78]) and ETV (OR  9,55
[1,53; 76,98]). Subgroup analysis in HBeAg-positive subjects revealed that TDV was
more effective than ADV (OR  21,60 [1,67; 285,40]) and LAM with respect to HBV
DNA clearance but no difference were found between TDV and ETV (OR  11,24
[0,53; 342,57). TDF showed similar efficacy to other NAs with respect to normaliza-
tion of alanine aminotransferase activity (ALT) and histological improvement. TDF
did not increase the risk of any and serious adverse events either in comparison
with PLC or with other NAs. The rates of ALT flares were similar in all groups.
CONCLUSIONS:TDF demonstrated the highest efficacy with respect to reduction of
viral load in patients with chronic HBV and maintained a very good safety profile.
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OBJECTIVES:A framework for comparative research is useful for health technology
assessment (HTA) and clinical decision making. The objective was to systemati-
cally assess efficacy and tolerability of 3rd agents, atazanavir/r (ATV/r) compared to
darunavir/r (DRV/r), lopinavir/r (LPV/r) and efavirenz (EFV), in treatment-naïve
HIV-1 infected adults. METHODS: A systematic literature search was conducted to
identify published randomized clinical trials (1-1-2000 to present), in which the
four anti-retroviral (ARV) treatments were used for these patients. Pooled esti-
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